Biopharmaceuticals

Restricting Private Labels is Anti-Consumer

Deborah Collier 06/12/2026

CCAGW Releases 2025 Congressional Ratings

Grigory Menshikov 06/03/2026

340B Abuse Spotlighted At House Ways and Means Committee Hearing

Eric Maus 05/14/2026

CCAGW Shares CAGW’s Comments on 340B Rebate Model Request for Information with House of Representatives

Eric Maus 04/20/2026

CCAGW Shares CAGW’s Comments on 340B Rebate Model Pilot Program Request for Information with Senate

Eric Maus 04/20/2026

The Hidden Costs of Importing Foreign Drug Price Controls Into Florida

Eric Maus 01/20/2026

Republican Study Committee Stands Firm on Budget Negotiations

This Week In Waste – January 9, 2026

Grigory Menshikov 01/09/2026

Inside Sources: States have taken deregulatory actions to get people back to work and enable better access to healthcare.

First Year of Trump Presidency Achieves Dramatic Cuts in Federal Regulations

Grigory Menshikov 01/09/2026

Open Architecture and Faster Timelines: Fixing Pentagon Procurement

Sean Kennedy 01/06/2026